AQUARK

28
AQUACULTURE AND AQUATIC ANIMAL HEALTH IN EUROPE: CURRENT AND EMERGING DISEASES IN MEDITERRANEAN MARICULTURE Dr. Panos Christofilogiannis Managing Director, AQUARK www.aquark.gr “Caring for health and welfare of fish: A critical success factor for aquaculture” Brussels, 16 -17 May 2013 - International Auditorium, Boulevard Roi Albert II 5, Brussels, Belgium

Transcript of AQUARK

Page 1: AQUARK

AQUACULTURE AND AQUATIC ANIMAL HEALTH IN EUROPE: CURRENT AND EMERGING DISEASES IN MEDITERRANEAN MARICULTURE

Dr. Panos Christofilogiannis

Managing Director, AQUARK www.aquark.gr

“Caring for health and welfare of fish: A critical success factor for aquaculture” Brussels, 16 -17 May 2013 - International Auditorium, Boulevard Roi Albert II 5, Brussels, Belgium

Page 2: AQUARK

DRIVERS • Diversification - New cultured species

• Introduction of Alien species

• Global warming – Climate Change

• Intensification – Strategic decisions – Spatial Planning

Page 3: AQUARK

DIVERSIFICATION

Page 4: AQUARK

DIVERSIFICATION

Page 5: AQUARK

DIVERSIFICATION

Seriola dumerilii Greater amberjack

Polyprion americanus Wreck fish Octopus vulgaris

Mullus surmulletus Striped red mullet

Page 6: AQUARK

ALIEN SPECIES

Page 7: AQUARK

GLOBAL WARMING – CLIMATE CHANGE

Page 8: AQUARK

GLOBAL WARMING – CLIMATE CHANGE

Page 9: AQUARK

EATiP projection APR 5%

Optimistic projection APR10% Sea bream

Sea bass

Meagre

Turbot Sole

INTENSIFICATION / SPATIAL PLANNING

Page 10: AQUARK

Epidemiology on the fish farm JAN FEB MAR APR MAY JUN JUL AUG SEPT OCT NOV DEC JAN FEB MARAPR MAY JUN JUL AUGSEPTOCT NOV DECEpidemiology Med AQUA

Myxobacteria

vibriosis periodvibriosis period North MedPasteurellosis periodPasteurellosis period North Med

Nodavirus (Sea bass)MonogeneaMicrocotyle infestation (sea bream)

Page 11: AQUARK

Pasteurellosis Vibriosis

MAIN BACTERIAL PATHOGENS

Bacterial Pathogen Species Listonella anguillarum (=Vibrio anguillarum)

Sea bass

Photobacterium damsela subsp. piscicida

Sea bass Sea bream

Tenecibaculum maritimum (=F. maritimus)

Sea bass Sea bream

Nocardia spp J Fish Dis. 2013 Feb;36(2):141-9.

Meagre

Aeromonas spp Sea bass

Streptocossus iniae Sea bass

Argyrosomus regius

Page 12: AQUARK

VIBRIOSIS • Vibrio anguillarum (I + II) / (V. ordalii = biotype II) • Sea bass (During ALL production circle) • Seasonal disease (Spring & Autumn) • Rapid temperature fluctuations can cause outbreaks • Outbreaks often stress-related • Haemorrhagic Septicaemia • Dark fish, Anaemia (gills very pale) • Haemorrhages around the mouth, fin edges and skin • Systemic septicaemia, Petechial haemorrhages on intestine • Renal and Heart necrosis • Spleen enlarged (and cherry red) • Inoculate from kidney onto TSA (non-selective) or TSBS agar • Incubate at 25oC for 24h

Page 13: AQUARK

PASTEURELLOSIS * Sea bass (During ALL production circle) * Sea bream (Mainly up to 40g) * Seasonal disease (June to October) * Haemorrhagic Septicaemia * Petechiae - Haemmorhagies in gut and gills * Renal and Heart necrosis * Nodules / necrosis in spleen (Chronic Pasteurellosis) * Inoculate from kidney onto TSA (non-selective) or TSBROTH / BHI agar * Incubate at 25oC for 48h (Pasteurella) * Bacterium appears as very small smooth, convex “grey-white” colonies (TSA)

Page 14: AQUARK

DIAGNOSIS OF BACTERIAL DISEASES ANTIBIOTIC TREATMENT

Tenacibaculum Vibrio spp

ANTIBIOTIC TREATMENT Different strains showing resistance

different antibiotic sensitivity profiles

• Oxytetracycline • Oxolinic Acid

• Flumequine

•Potentiated Sulphonamides

Page 15: AQUARK

VIRAL ENCEPHALOPATHY AND RETINOPATHY (VER) ANNUAL ESTIMATED COST: MORE THAN 18 MILLION EUROS

Page 16: AQUARK

Sea Bass and Sea Bream Pathogens

Lymphocystis

Monogeneans

Cryptocaryon Epitheliocystis Trichodina Ceratomyxa

Myxidium

Sphaerospora

Major need for licensed antiparasitic compounds

Page 17: AQUARK

MICROCOTYLE INFESTATION

1 hour - 200ppm Formalin bath 30 min - 300ppm Formalin bath

Repeat after 5 days

Organic Iron: 2000 ppm in feed for 15-20 days

Page 18: AQUARK

Red lesions in Sea bream Intracytoplasmatic organisms (Chlamydia like)

Source: Sito Padros

Page 19: AQUARK

Lernathropus kroyeri in sea bass

Page 20: AQUARK

Lernathropus kroyeri in sea bass

Page 21: AQUARK

Diplectanum aequans Ceratothoa oestroides

Page 22: AQUARK

Tenacibaculum maritimum

Solea senegalensis Solea solea

Parasitic Pathogen

Host

Philasterides dicentrarchi

Turbot, sole

Enteromyxum scophthalmi

Turbot

Microsporidium sp

Turbot

Trichodina sp Turbot, Sole, Red Sea Bream, Striped red mullet, octopus

Ceratomyxa sp Red Sea Bream, Striped red mullet

Icthobodo sp Turbot, Solea, Red Sea Bream, Striped red mullet

Copepod sp Wild sole

Bacterial Pathogen Species Listonella anguillarum (=Vibrio anguillarum)

Turbot, Solea, Red Sea Bream Striped red mullet

Tenecibaculum maritimum (=F. maritimus)

Turbot, Senegalensis sole, Commun sole

Aeromonas salmonicida subsp salmonicida

Turbot

Vibrio sp (V. splendidus, V pelagius, V harveyi..)

Turbot, Solea, Red Sea Bream, Striped red mullet, octopus

Pseudomonas Turbot, Solea, Red Sea Bream, Striped red mullet, octopus

Edwarsiella tarda Turbot

Pseudomonas anguilliseptica

Turbot

Pseudomonas sp Turbot, Solea, Red Sea Bream, Striped red mullet, octopus

Streptococcus parauberis

Turbot

Scophthalmus maximus

Enteromyxum scophthalmi

Philasterides dicentrarchi

Page 23: AQUARK

VACCINATION STRATEGIES – SEA BASS

Page 24: AQUARK

VACCINATION STRATEGIES – SEA BREAM

Page 25: AQUARK

Vaccine technologies-delivery Need to fast track approval of new generation vaccines

Recombinant vaccines for aquaculture: IPNV, SRS ,ISAV (only salmon)

Page 26: AQUARK

• Immersion (V+P) vaccine market : 800.000 Euros • Injection (V+P) vaccine market: 2.5 mio Euros • Relatively Low Vaccine Dose Cost: Double injection vaccination strategy cost is 4 times lower per Fish than salmon (5valent strategy cost) • Introduction of NODAVIRUS vaccine is going to Double the vaccine market in the Med.

Current market of fish vaccines 3,5 million Euros

Presenter
Presentation Notes
3 to 3,9 eurocents Vaccine 0,8 -1,6 (26,6% - 41%) Operator 1,7 (56% to 43% ) Other 0,6
Page 27: AQUARK

Future fish health management

• Increased application of vaccination programmes • Faster development of new generation vaccines (EU initiative required) • Increased vaccine market value (motivation) due to:

• increased vaccination adoption (e.g. Spain) • increased expected production • new vaccines (Nodavirus etc) • new fast growers pathologies

• New licensed antiparasitic compounds • Effective genetic selection programmes (“robustness”)

Page 28: AQUARK

THANK YOU FOR YOUR ATTENTION

“Caring for health and welfare of fish: A critical success factor for aquaculture” Brussels, 16 -17 May 2013 - International Auditorium, Boulevard Roi Albert II 5, Brussels, Belgium